Evidence map›Paper›PMID 38646526›Full record

ReviewFrontiers in immunology2024

Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling.

Catalina Argandona Lopez, Amanda M Brown

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Catalina Argandona LopezDivision of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Amanda M BrownDivision of Neuroimmunology, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Johns Hopkins University · US

Funding

The HIV-Osteopontin-HAND Triad: Inflammation and Neuronal Injury in the BrainR01NS102006 · NINDS · JOHNS HOPKINS UNIVERSITY · PI AMANDA MARIA BROWN · 2016 to 2026
$6.4M
Toward Understanding the Role of Adult Human Microglia in the Ongoing Persistence of HIV and its Associated Neuropsychiatric ComorbiditiesR21MH128152 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BROWN, AMANDA MARIA · 2021 to 2022
$450k
NIMH NIH HHS R21 MH128152NINDS NIH HHS R01 NS102006
6 · The paper itself

Abstract

HIV-infection of microglia and macrophages (MMs) induces neuronal injury and chronic release of inflammatory stimuli through direct and indirect molecular pathways. A large percentage of people with HIV-associated neurologic and psychiatric co-morbidities have high levels of circulating inflammatory molecules. Microglia, given their susceptibility to HIV infection and long-lived nature, are reservoirs for persistent infection. MMs and neurons possess the molecular machinery to detect pathogen nucleic acids and proteins to activate innate immune signals. Full activation of inflammasome assembly and expression of IL-1β requires a priming event and a second signal. Many studies have demonstrated that HIV infection alone can activate inflammasome activity. Interestingly, secreted phosphoprotein-1 (

Indexed as

HIV InfectionsInflammasomesMicrogliaNeuronsOsteopontinSignal TransductionTOR Serine-Threonine KinasesAnimalsHumansInflammasomesMTOR protein, humanOsteopontinTOR Serine-Threonine Kinaseshuman immunodeficiency virusintegrinslatencymicroglianeurodegenerationneuroimmunologyneuroinflammationneurological disorders

Identifiers

PMID38646526
PMCPMC11032048
OpenAlexW4393986793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.